Skip to main content

Table 3 Tau PTM events increased in at least one Braak III–IV tissue. Statistical significance was determined with Omnibus test

From: A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain

PTM events

P-value

adjusted P-value

pS198

0.0007346

0.003306

pS199

0.0000003316

0.000005968

pT231

0.001081

0.003891

pS416

0.0004662

0.002797

pS422

0.00004812

0.0004331